Eris Lifesciences Limited has announced that Krishnakumar Vaidyanathan, Executive Director and Chief Operating Officer, will resign from the company, with effect from the close of business hours on September 30, 2026, to pursue professional opportunities outside the firm. In his resignation letter to the board, Vaidyanathan expressed gratitude for the support and cooperation extended during his tenure. The company stated that the resignation letter has been tendered and accepted, with a waiver of the applicable notice period.
The development marks a notable leadership transition at Eris as it continues to navigate a competitive landscape in the life sciences space. With the COO role set to be vacant, questions are likely to arise about how the company will manage its day-to-day operations in the near term while it charts the path forward.
Milind Talegaonkar, Company Secretary & Compliance Officer, confirmed that the resignation has been accepted with waiver of the notice period. No immediate successor has been announced, and the company did not disclose a timeline for filling the position.
As Eris progresses, market observers will be watching how the leadership transition influences execution across the organization and the actions the board takes to sustain momentum during this period of change.